DXB Ann: FDA Confirms Inclusion of Paediatrics in ACTION3 Study - 12th Jan 2023, 9:16am

annb0t

annb0t

Top 20
DXB Ann: FDA Confirms Inclusion of Paediatrics in ACTION3 Study
Price Sensitive: Y
Date: 12th Jan 2023, 9:16am

>>> Read announcement: Google: DXB Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
DXB Ann: FDA Approves Qytovra Brand Name - 25th Sep 2023, 9:23am
Replies
0
Views
63
annb0t
annb0t
annb0t
DXB Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS - 9th May 2022, 9:14am
Replies
0
Views
359
annb0t
annb0t
annb0t
DXB Ann: Notification of cessation of securities - DXB - 31st Oct 2023, 1:22pm
Replies
0
Views
81
annb0t
annb0t
annb0t
DXB Ann: Quarterly Appendix 4C and Activities Report - 30th Oct 2023, 9:09am
Replies
0
Views
89
annb0t
annb0t
annb0t
DXB Ann: Notification of cessation of securities - DXB - 25th Oct 2023, 11:12am
Replies
0
Views
85
annb0t
annb0t
Top Bottom